Dr. Anmol Kapoor is a pioneering leader in precision healthcare, artificial intelligence, and blockchain technology who is revolutionizing modern medicine. As the founder of CardiAI and BioAro, he leads innovations in genomics, longevity medicine, and personalized healthcare. Dr. Kapoor holds over seventy patents in diverse fields including AI, genomics, quantum sciences, medical devices, supplements, and digital health. His groundbreaking work has significantly advanced diagnostic methods, treatment outcomes, and overall healthcare strategies worldwide. A key innovator, Dr. Kapoor is leveraging blockchain through BioAro’s BioChain platform, which securely manages patient data while supporting personalized health assessments such as DNA NFTs and Anryton. These technologies empower individuals with secure digital genomic records, maintaining stringent data privacy. He also drives progress in sports medicine and longevity via initiatives like The BioSport and PanOmiQ, a precise whole genome sequencing platform. Recently, he launched the first Precision Health and Longevity Clinic in Dubai under the Biongevity initiative, demonstrating his commitment to extending global healthspan. Through his integration of AI, blockchain, and genomics, Dr. Kapoor is redefining precision medicine. His visionary approach promises a future where healthcare is personalized, transformative, and more effective for everyone, making a lasting impact on the industry. Thus, his work drives progress.